Literature DB >> 22321112

Aortic regurgitation caused by Behçet's disease: surgical experience during an 11-year period.

Wei-Guo Ma1, Jun Zheng, Jun-Ming Zhu, Yong-Min Liu, Ming Li, Li-Zhong Sun.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Aortic regurgitation (AR) caused by Behçet's disease is a rare clinical condition and surgical experience is limited. Many patients undergoing simple aortic valve replacement (AVR) required a second or third operation as a result of prosthetic valve dehiscence. We analyze our experience with surgical management for AR in Behçet's disease during an 11-year period.
METHODS: From April 1997 through December 2008, 10 male patients (mean age, 38.4 ± 6.9 years) with AR caused by Behçet's disease underwent surgical treatment. The primary procedures were AVR in seven cases and aortic root replacement in three (two Bentall, one Cabrol). The duration of follow-up was 5.3 ± 3.6 years.
RESULTS: In the seven patients with simple AVR, valve dehiscence occurred in six after an interval of 2.9 ± 1.7 months, necessitating 11 reoperations (four redo AVRs, one redo redo-AVR, four aortic root replacements, and two heart transplants) with one early death. In aortic root replacement patients, two Bentall patients survived and required no reintervention, and the Cabrol patient died from electromechanical uncoupling one year postoperatively. Of the seven survivors, the definite procedure was aortic root replacement in four cases, heart transplantation in two, and AVR in one.
CONCLUSIONS: The rate of valve dehiscence was high after isolated AVR in patients with AR caused by Behçet's disease. At the first operation, aortic root replacement should be the procedure of choice, preferably with a homograft. Heart transplantation might be a feasible alternative to aortic root replacement in selected patients.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22321112     DOI: 10.1111/j.1540-8191.2011.01392.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  8 in total

Review 1.  Pathology of the Aortic Valve: Aortic Valve Stenosis/Aortic Regurgitation.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-07-05       Impact factor: 2.931

Review 2.  Cardiac manifestations in Behcet's disease.

Authors:  Selami Demirelli; Husnu Degirmenci; Sinan Inci; Arif Arisoy
Journal:  Intractable Rare Dis Res       Date:  2015-05

Review 3.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

4.  Serum uric acid could be served as an independent marker for increased risk and severity of ascending aortic dilatation in Behçet's disease patients.

Authors:  Jianfei Cai; Yinjia Zhang; Jun Zou; Yan Shen; Dan Luo; Huafang Bao; Yong Chen; Jingfen Ye; Jian-Long Guan
Journal:  J Clin Lab Anal       Date:  2018-08-12       Impact factor: 2.352

5.  An adolescent with Behçet's aortitis mimicking infective endocarditis: a case report.

Authors:  Kaoru Hattori; Mimiko Tabata; Tohru Nojiri; Atsushi Kurata
Journal:  Eur Heart J Case Rep       Date:  2021-09-16

6.  The surgical outcomes of aortic valve replacement in patients with aortic valve lesions caused by Behcet's disease: lessons we learned.

Authors:  Xiaoning Sun; Li Yuan; Junjiang Liu; Quanlin Yang; Huan Liu; Hongqiang Zhang; Chunsheng Wang
Journal:  Ann Transl Med       Date:  2021-10

7.  Long-Term Outcomes of Homografts in the Aortic Valve and Root Position: A 20-Year Experience.

Authors:  Joo Yeon Kim; Joon Bum Kim; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-08-05

8.  Prognostic analysis of Behçet's disease with aortic regurgitation or involvement.

Authors:  X Li; X Wen; J Xu; Q Lin; L Liu
Journal:  Neth Heart J       Date:  2021-04-20       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.